US government shuts down after Senate blocks spending bill, Donald Trump slams Democrats

Agencies
January 20, 2018

Washington, Jan 20: The U.S. Senate was short of the votes needed to approve a bill to keep the federal government running as a midnight deadline loomed on Friday night, although high-level negotiations continued.

In a dramatic late-night session, Senate majority leader Mitch McConnell left voting open despite appearing to fall well short of the 60 votes needed to keep alive a stopgap bill that would fund the government through Feb. 16.

As the clock ticked toward midnight, McConnell and Senate Democratic leader Chuck Schumer huddled in negotiations in a room just off the Senate floor.

Without some type of funding bill, the U.S. government technically will run out of money right after midnight, on the first anniversary of President Donald Trump`s inauguration. That would leave scores of federal agencies across the country unable to continue operating, and hundreds of thousands of "non-essential" federal workers would be put on temporary unpaid leave.

The Republican-controlled House of Representatives passed a stopgap funding measure on Thursday. But Republicans then needed the support of at least 10 Democrats to pass the bill in the Senate.

Democratic leaders demanded that the measure include protections for hundreds of thousands of young undocumented immigrants known as "Dreamers" who arrived in the United States as children with their parents. Republicans refused and neither side has been willing to back down.

Trump last week rejected a bipartisan proposal, saying he wanted to include any deal for Dreamers in a bigger legislative package that also boosts funding for a border wall and tighter security at the U.S. border with Mexico.

In a shutdown, "essential" employees who deal with public safety and national security would keep working. That includes more than 1.3 million people on active duty in the military who would be required to work and would not be paid until funding is renewed.

Although past government shutdowns have done little lasting damage to the U.S. economy, they can rattle financial markets.

A new shutdown now would trigger a political battle between Democrats and Republicans over who is to blame.

This week`s showdown follows a months-long struggle in Congress to agree on government funding levels and the immigration issue.

Democrats have demanded the bill include protections from deportation for about 700,000 Dreamers, who are predominantly from Mexico and Central America and were given temporary legal status under the Deferred Action for Childhood Arrivals program started by former President Barack Obama.

In September, Trump announced he was ending the program and giving Congress until March 5 to come up with a legislative replacement.

Trump pointed the finger at his political rivals earlier on Friday.

"Democrats are needed if it is to pass in the Senate - but they want illegal immigration and weak borders. Shutdown coming?" he said.

Democrats say the search for a deal has been hurt by Trump sending contradictory messages about what kind of bipartisan immigration proposal he would accept.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 25,2020

Beijing:  Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 28,2020

Paris, Jun 28: More than 10 million cases of the new coronavirus have been officially declared around the world, half of them in Europe and the United States, according to an AFP tally on Sunday based on official sources.

At least 10,003,942 infections, including 498,779 deaths, have been registered globally.

Europe remains the hardest hit continent with 2,637,546 cases including 195,975 fatalities, while the United States has 2,510,323 infections including 125,539 deaths.

The rate of infections worldwide continues to rise, with one million new cases recorded in just six days.

The tallies, using data collected by AFP from national authorities and information from the World Health Organization (WHO), probably reflect only a fraction of the actual number of infections.

Many countries are testing only symptomatic or the most serious cases and some do not have the capacity to carry out widescale testing.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 14,2020

Brasilia, Jul 14: Brazil has reported new 20,286 coronavirus cases in last 24 hours taking the country's total to 1.8 million, Sputnik reported citing the health ministry.

The country's death toll has increased by 733 in the same period of time. The death toll from the infection has touched 72,833.

Over 1.1 million people have recovered from COVID-19 in Brazil since the start of the epidemic in the country, according to the health ministry.

Brazil has the second-highest coronavirus death toll, it is surpassed only by the United States.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.